Squamous dysplasia-The precursor lesion for esophageal squamous cell carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 4, 2013, Pages 540-552

  Taylor, Philip R ^a   Abnet, Christian C ^b   Dawsey, Sanford M ^b  

^a Genetic Epidemiology Branch   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; BIOLOGICAL MARKER; CALCIUM; CELECOXIB; MULTIVITAMIN; RETINOL; RIBOFLAVIN; SELENIUM; ZINC;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CHINA; EARLY DIAGNOSIS; ENDOSCOPIC THERAPY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HIGH RISK POPULATION; HUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TEA;

ADULT; CARCINOMA, SQUAMOUS CELL; CHINA; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; HYPERPLASIA; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 84876517706     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1347     Document Type: Article

References (97)

1. Jemal A, Bray F, CenterMM,Ferlay J, Ward E, FormanD. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Munoz N, Crespi M, Grassi A, Qing WG, Qiong S, Cai LZ. Precursor lesions of oesophageal cancer in high-risk populations in Iran and China. Lancet 1982;1:876-9. (Pubitemid 12140279)
3. Qiu SL, Yang GR. Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer 1988;62:551-7.
4. Dawsey SM, Lewin KJ, Wang GQ, Liu FS, Nieberg RK, Yu Y, et al. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 1994;74:1686-92. (Pubitemid 24301820)
5. Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 2005;54:187-92. (Pubitemid 40139230)
6. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-74.
7. Weinstein WM,Bogoch ER, Bowes KL. The normal human esophageal mucosa: a histological reappraisal. Gastroenterol 1975;68:40-4.
8. Tumor Prevention TaRGCH, Esophageal Cancer Research Group CAoMSP, Linhsien County People's Hospital H. Pathology of early esophageal squamous carcinoma. Chin Med J 1977;3:180-92.
9. Mitros FA. Inflammatory and neoplastic diseases of the esophagus. In: Appleman HD, editor. Pathology of the esophagus, stomach and duodenum. New York: Churchill Livingstone; 1984. p. 1-35.
10. Dawsey SM, Lewin KJ, Liu FS, Wang GQ, Shen Q. Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Cancer 1994;73:2027-37. (Pubitemid 24107953)
11. Hu N, Huang J, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang C, et al. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res 2001;7:883-91. (Pubitemid 32708725)
12. Abedi-Ardekani B, Kamangar F, Sotoudeh M, Villar S, Islami F, Aghcheli K, et al. Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, Iran. PLoS ONE 2011;6:e29488.
13. Xing EP, Nie Y,Wang LD, Yang GY, Yang CS. Aberrantmethylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis 1999;20:77-84. (Pubitemid 29033848)
14. Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, et al. Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res 2011;17:2955-66.
15. Agrawal N, Jiao Y, Bettegowda C, Hutfless SM, Wang Y, David S, et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2012;2:899-905.
16. Wang LD, Hong JY, Qiu SL, Gao H, Yang CS. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 1993;53:1783-7. (Pubitemid 23127103)
17. Roye GD, Myers RB, Brown D, Poczatek R, Beenken SW, Grizzle WE. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer 1996;69:254-8. (Pubitemid 26298286)
18. Zhou Q, Dong WL, Du F, Zhou Y, Rui ZY, Liu B, et al. Changes of TGFbeta1 and TGFbetaRII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China. Dis Esophagus 2002;15:74-9. (Pubitemid 34812003)
19. Chen H, Wang LD, Guo M, Gao SG, Guo HQ, Fan ZM, et al. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol 2003;9:16-21. (Pubitemid 36131270)
20. Kimos MC, Wang S, Borkowski A, Yang GY, Yang CS, Perry K, et al. Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression. Int J Cancer 2004;111:415-7. (Pubitemid 38998823)
21. Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, et al. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer 2006;6:296.
22. Bai P, Xiao X, Zou J, Cui L, Bui Nguyen TM, Liu J, et al. Expression of p14(ARF), p15(INK4b), p16(INK4a) and skp2 increases during esophageal squamous cell cancer progression. Exp Ther Med 2012;3: 1026-32.
23. Yang L, Wang LS, Chen XL, Gatalica Z, Qiu S, Liu Z, et al. Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus. Int J Biochem Mol Biol 2012;3: 46-57.
24. Shimada M, Yanagisawa A, Kato Y, Inoue M, Shiozaki H, Monden M, et al. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions. Genes Chromosomes Cancer 1996;15:165-9. (Pubitemid 26112508)
25. Roth MJ, Hu N, Emmert-Buck MR, Wang QH, Dawsey SM, Li G, et al. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma. Cancer Res 2001; 61:4098-104. (Pubitemid 32720977)
26. Shima H, Hiyama T, Tanaka S, Ito M, Kitadai Y, Yoshihara M, et al. Frequent loss of heterozygosity on chromosome 10p14-p15 in esophageal dysplasia and squamous cell carcinoma. Oncol Rep 2004;12: 333-7.
27. Liu M, Zhang F, Liu S, Zhao W, Zhu J, Zhang X. Loss of heterozygosity analysis of microsatellites on multiple chromosome regions in dysplasia and squamous cell carcinoma of the esophagus. Exp Ther Med 2011;2:997-1001.
28. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 1994;54:4342-6.
29. Nie Y, Liao J, Zhao X, Song Y, Yang GY, Wang LD, et al. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 2002; 23:1713-20. (Pubitemid 35214957)
30. Roth MJ, Abnet CC, Hu N, Wang QH, Wei WQ, Green L, et al. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. Oncol Rep 2006;15:1591-7.
31. Ishii T, Murakami J, Notohara K, Cullings HM, Sasamoto H, Kambara T, et al. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa. Gut 2007;56:13-9. (Pubitemid 46044883)
32. Adams L, Roth MJ, Abnet CC, Dawsey SP, Qiao YL, Wang GQ, et al. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prev Res 2008;1: 357-61.
33. Lu J, Liu Z, Xiong M, Wang Q, Wang X, Yang G, et al. Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001;91:288-94. (Pubitemid 32049620)
34. Zhou J, Zhao LQ, Xiong MM, Wang XQ, Yang GR, Qiu ZL, et al. Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World J Gastroenterol 2003;9:9-15. (Pubitemid 36131269)
35. Kumar A, Chatopadhyay T, Raziuddin M, Ralhan R. Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray. Int J Cancer 2007;120:230-42. (Pubitemid 44956831)
36. Killian J, Roth M, Singh P, Walker R, Chen Y, Wang GQ, et al. Large scale DNA methylation profiling and high-resolution comparative genomic hybridization of preneoplastic and invasive esophageal squamous cell carcinoma: Discovery of early detection markers. Cancer Prev Res 2008;1:B50.
37. Robertson EV, Jankowski JA. Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility. Am J Gastroenterol 2008;103:443-9. (Pubitemid 351248711)
38. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010;42:764-7.
39. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010;42:759-63.
40. Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y, et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet 2011;43:679-84.
41. Wu C, Kraft P, Zhai K, Chang J, Wang Z, Li Y, et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 2012;44:1090-7.
42. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, et al. Performance of common genetic variants in breastcancer risk models. N Engl J Med 2010;362:986-93.
43. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1404-13. (Pubitemid 37220460)
44. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005;113:456-63. (Pubitemid 40038715)
45. Gao Y, Hu N, Han XY, Ding T, Giffen C, Goldstein AM, et al. Risk factors for esophagel and gastric cancers in Shanxi Province, China: a case- control study. Cancer Epidemiol 2011;35:e91-e99.
46. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 2008;98:1857-63. (Pubitemid 351748837)
47. Abedi-Ardekani B, Kamangar F, Hewitt SM, Hainaut P, Sotoudeh M, Abnet CC, et al. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut 2010;59:1178-83.
48. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85: 1483-92. (Pubitemid 23269183)
49. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 2000;92: 1753-63.
50. Abnet CC, Qiao YL, Dawsey SM, Buckman DW, Yang CS, Blot WJ, et al. Prospective study of serum retinol, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin and esophageal and gastric cancers in China. Cancer Causes Control 2003;14:645-55. (Pubitemid 37211121)
51. Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, et al. Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1414-6. (Pubitemid 37220461)
52. Murphy G, Fan JH, Mark SD, Dawsey SM, Selhub J, Wang J, et al. Prospective study of serum cysteine levels and oesophageal and gastric cancers in China. Gut 2011;60:618-23.
53. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009;338:b929.
54. Crespi M, Munoz N, Grassi A, Aramesh B, Amiri G, Mojtabai A, et al. Oesophageal lesions in northern Iran: a premalignant condition? Lancet 1979;2:217-21. (Pubitemid 10104832)
55. Roth MJ, Liu SF, Dawsey SM, Zhou B, Copeland C, Wang GQ, et al. Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer 1997;80:2047-59. (Pubitemid 27506017)
56. Lu XJ, Chen ZF, Guo CL, Li SS, Bai WL, Jin GL, et al. Endoscopic survey of esophageal cancer in a high-risk area of China. World J Gastroenterol 2004;10:2931-5.
57. Pan QJ, Roth MJ, Guo HQ, Kochman ML, Wang GQ, Henry M, et al. Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Linxian, China. Acta Cytol 2008;52: 14-23. (Pubitemid 351155775)
58. He Z, Zhao Y, Guo C, Liu Y, Sun M, Liu F, et al. Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey. Br J Cancer 2010;103:1085-8.
59. Etemadi A, Abnet CC, Golozar A, Malekzadeh R, Dawsey SM. Modeling the risk of esophageal squamous cell carcinoma and squamous dysplasia in a high risk area in Iran. Arch Iran Med 2012;15:18-21.
60. Wei WQ, Abnet CC, Lu N, Roth MJ, Wang GQ, Dye BA, et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut 2005;54:759-63. (Pubitemid 40732088)
61. Abnet CC, Chen W, Dawsey SM, Wei WQ, Roth MJ, Liu B, et al. Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev 2007;16:1889-93. (Pubitemid 47450522)
62. Kamangar F, Diaw L, Wei WQ, Abnet CC, Wang GQ, Roth MJ, et al. Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer 2009;124:456-60.
63. Li T, Lu ZM, Chen KN, Guo M, Xing HP, Mei Q, et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 2001;22:929-34. (Pubitemid 32514960)
64. Zhou XB, Guo M, Quan LP, Zhang W, Lu ZM, Wang QH, et al. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 2003;9:1170-3. (Pubitemid 36805645)
65. Kamangar F, Qiao YL, Schiller JT, Dawsey SM, Fears T, Sun XD, et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer 2006;119:579-84. (Pubitemid 43955711)
66. Koshiol J, Wei WQ, Kreimer AR, Chen W, Gravitt P, Ren JS, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2010;127:93-100.
67. Sitas F, Egger S, Urban MI, Taylor PR, Abnet CC, Boffetta P, et al. InterSCOPE study: associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst 2012;104:147-58.
68. Guo F, Liu Y, Wang X, He Z, Weiss NS, Madeleine MM, et al. Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev 2012;21: 780-5.
69. Gao GF, Roth MJ, Wei WQ, Abnet CC, Chen F, Lu N, et al. No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer 2006; 119:1354-9. (Pubitemid 44258811)
70. Chang F, Shen Q, Zhou J,WangC,WangD, Syrjanen S, et al. Detection of human papillomavirus DNA in cytologic specimens derived from esophageal precancer lesions and cancer. Scand J Gastroenterol 1990;25:383-8. (Pubitemid 20184829)
71. Chang F, Syrjanen S, Shen Q, Ji HX, Syrjanen K. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int J Cancer 1990;45:21-5. (Pubitemid 20032092)
72. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
73. Aghcheli K, Marjani HA, Nasrollahzadeh D, Islami F, Shakeri R, Sotoudeh M, et al. Prognostic factors for esophageal squamous cell carcinoma- a population-based study in Golestan Province, Iran, a high incidence area. PLoS ONE 2011;6:e22152.
74. Wang GQ, Jiao GG, Chang FB, Fang WH, Song JX, Lu N, et al. Longterm results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 2004;77:1740-4. (Pubitemid 38530016)
75. Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998;83:220-31. (Pubitemid 28317800)
76. Bergman JJ, Zhang YM, He S, Weusten B, Xue L, Fleischer DE, et al. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc 2011;74:1181-90.
77. Dawsey SM, Fleischer DE, Wang GQ, Kidwell JA, Zhou B, Tio TL, et al. Endoscopic and histologi progression of untreated squamous esophageal neoplasia in asymptomatic patients from Linxian, China: implications for screening. Gastroenterol 1997;112:A553.
78. Inoue H, Minami H, Kaga M, Sato Y, Kudo SE. Endoscopic mucosal resection and endoscopic submucosal dissection for esophageal dysplasia and carcinoma. Gastrointest Endosc Clin N Am 2010;20: 25-34.
79. Zhang YM, Boerwinkel DF, He S, Weusten BL, Xue LY, Fleischer DE, et al. Prospective feasibility study on the use of multiband mucosectomy for endoscopic resection of early squamous neoplasia in the esophagus. Endoscopy 2013;45:167-73.
80. Oyama T, Tomori A, Hotta K, Morita S, Kominato K, Tanaka M, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 2005;3:S67-S70. (Pubitemid 40977886)
81. Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 1993;85:1492-8. (Pubitemid 23269184)
82. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, et al. Total and cancer mortality following supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 2009;101:507-18.
83. Munoz N, Wahrendorf J, Bang LJ, Crespi M, Thurnham DI, Day NE, et al. No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China. Lancet 1985;2:111-4. (Pubitemid 15046291)
84. Munoz N, Hayashi M, Bang LJ, Wahrendorf J, Crespi M, Bosch FX. Effect of riboflavin, retinol, and zinc on micronuclei of buccal mucosa and of esophagus: a randomized double-blind intervention study in China. J Natl Cancer Inst 1987;79:687-91. (Pubitemid 17145696)
85. Lin PZ, Zhang JS, Cao SG, Han R, Xu SP, Xu ZP, et al. Second line prevention from esophageal cancer inhibitory therapy to block precancerous lesions. Chin J Cancer Res 1988;1:37-46.
86. Wang LD, Qiu SL, Yang GR, Lipkin M, Newmark HL, Yang CS. A randomized double-blind intervention study on the effect of calcium supplementation on esophageal precancerous lesions in a high-risk population in China. Cancer Epidemiol Biomarkers Prev 1993; 2:71-8.
87. Wang GQ, Dawsey SM, Li JY, Taylor PR, Li B, Blot WJ, et al. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev 1994;3:161-6. (Pubitemid 24170060)
88. Dawsey SM, Wang GQ, Taylor PR, Li JY, Blot WJ, Li B, et al. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the dysplasia trial in Linxian, China. Cancer Epidemiol Biomarkers Prev 1994;3:167-72. (Pubitemid 24170061)
89. Rao M, Liu FS, Dawsey SM, Yang K, Lipkin M, Li JY, et al. Effects of vitamin/mineral supplementation on the proliferation of esophageal squamous epithelium in Linxian, China. Cancer Epidemiol Biomarkers Prev 1994;3:277-9. (Pubitemid 24172543)
90. Mark SD, Liu SF, Li JY, GailMH, Shen Q,DawseySM, et al. The effect of vitamin and mineral supplementation on esophageal cytology: results from the Linxian Dysplasia Trial. Int J Cancer 1994;57:162-6. (Pubitemid 24144202)
91. Wang LD, Zhou Q, Feng CW, Liu B, Qi YJ, Zhang YR, et al. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Gan To Kagaku Ryoho 2002;29(Suppl 1):159-72.
92. Limburg PJ, Wei W, Ahnen DJ, Qiao Y, Hawk ET, Wang G, et al. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 2005;129:863-73. (Pubitemid 41242679)
93. He Y, Ye L, Shan B, Song G, Meng F, Wang S. Effect of riboflavinfortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China. Asian Pac J Cancer Prev 2009;10:619-22.
94. Chen T, Yan F, Qian J, Guo M, Zhang H, Tang X, et al. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res 2012;5: 41-50.
95. Lin P, Zhang J, Rong Z, Han R, Xu S, Gao R, et al. [Studies on medicamentous inhibitory therapy for esophageal precancerous lesions-3- and 5-year inhibitory effects of antitumor-B, retinamide and riboflavin]. Proc Chin Acad Med Sci Peking Union Med Coll 1990;5:121-9.
96. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006;98:748-56. (Pubitemid 43983298)
97. Kadri SR, Lao-Sirieix P, O'Donovan M, Debiram I, Das M, Blazeby JM, et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 2010;341: c4372.